Business Wire
BusinessSalesforce and other enterprise software vendors push back on “SaaSpocalypse” fears as AI becomes a new demand narrativeThe Apex TimesBusinessJim Cramer and Ross Gerber push back on margin worries as investors parse Nvidia’s latest quarterThe Apex TimesBusinessJohnson & Johnson reports FDA approval for autoimmune drug in rare blood diseaseThe Apex TimesBusinessNvidia’s Jensen Huang tells Jim Cramer that revenue growth is “not easy” even after a sharp quarterThe Apex TimesBusinessSalesforce CEO points to a record quarter as AI fears about replacing enterprise software fadeThe Apex TimesBusinessNetflix rolls out main poster and trailer for “Delusion,” setting an eye-opening September 24 releaseThe Apex TimesBusinessModerna’s market value is being priced more for its pipeline than its current revenue, analysis saysThe Apex TimesBusinessPalantir’s Pentagon Maven milestone and guidance raise reshape how investors view its government businessThe Apex TimesBusinessNvidia on pace for record growth as Wall Street digests guidance and pace of revenue expansionThe Apex TimesBusinessCVS Health refreshes its board with a data-and-analytics leader and spotlights youth soccer amid questions about its investment narrativeThe Apex TimesBusinessConsumer stocks outside the AI trade have risen sharply this year, trouncing Nvidia in a new market comparisonThe Apex TimesBusinessTarget introduces “Beauty Studio,” pitching a curated cosmetics shop-in-shop with 1,600 products and 90 brandsThe Apex TimesBusinessSalesforce and other enterprise software vendors push back on “SaaSpocalypse” fears as AI becomes a new demand narrativeThe Apex TimesBusinessJim Cramer and Ross Gerber push back on margin worries as investors parse Nvidia’s latest quarterThe Apex TimesBusinessJohnson & Johnson reports FDA approval for autoimmune drug in rare blood diseaseThe Apex TimesBusinessNvidia’s Jensen Huang tells Jim Cramer that revenue growth is “not easy” even after a sharp quarterThe Apex TimesBusinessSalesforce CEO points to a record quarter as AI fears about replacing enterprise software fadeThe Apex TimesBusinessNetflix rolls out main poster and trailer for “Delusion,” setting an eye-opening September 24 releaseThe Apex TimesBusinessModerna’s market value is being priced more for its pipeline than its current revenue, analysis saysThe Apex TimesBusinessPalantir’s Pentagon Maven milestone and guidance raise reshape how investors view its government businessThe Apex TimesBusinessNvidia on pace for record growth as Wall Street digests guidance and pace of revenue expansionThe Apex TimesBusinessCVS Health refreshes its board with a data-and-analytics leader and spotlights youth soccer amid questions about its investment narrativeThe Apex TimesBusinessConsumer stocks outside the AI trade have risen sharply this year, trouncing Nvidia in a new market comparisonThe Apex TimesBusinessTarget introduces “Beauty Studio,” pitching a curated cosmetics shop-in-shop with 1,600 products and 90 brandsThe Apex TimesBusinessSalesforce and other enterprise software vendors push back on “SaaSpocalypse” fears as AI becomes a new demand narrativeThe Apex TimesBusinessJim Cramer and Ross Gerber push back on margin worries as investors parse Nvidia’s latest quarterThe Apex TimesBusinessJohnson & Johnson reports FDA approval for autoimmune drug in rare blood diseaseThe Apex TimesBusinessNvidia’s Jensen Huang tells Jim Cramer that revenue growth is “not easy” even after a sharp quarterThe Apex TimesBusinessSalesforce CEO points to a record quarter as AI fears about replacing enterprise software fadeThe Apex TimesBusinessNetflix rolls out main poster and trailer for “Delusion,” setting an eye-opening September 24 releaseThe Apex TimesBusinessModerna’s market value is being priced more for its pipeline than its current revenue, analysis saysThe Apex TimesBusinessPalantir’s Pentagon Maven milestone and guidance raise reshape how investors view its government businessThe Apex TimesBusinessNvidia on pace for record growth as Wall Street digests guidance and pace of revenue expansionThe Apex TimesBusinessCVS Health refreshes its board with a data-and-analytics leader and spotlights youth soccer amid questions about its investment narrativeThe Apex TimesBusinessConsumer stocks outside the AI trade have risen sharply this year, trouncing Nvidia in a new market comparisonThe Apex TimesBusinessTarget introduces “Beauty Studio,” pitching a curated cosmetics shop-in-shop with 1,600 products and 90 brandsThe Apex TimesBusinessSalesforce and other enterprise software vendors push back on “SaaSpocalypse” fears as AI becomes a new demand narrativeThe Apex TimesBusinessJim Cramer and Ross Gerber push back on margin worries as investors parse Nvidia’s latest quarterThe Apex TimesBusinessJohnson & Johnson reports FDA approval for autoimmune drug in rare blood diseaseThe Apex TimesBusinessNvidia’s Jensen Huang tells Jim Cramer that revenue growth is “not easy” even after a sharp quarterThe Apex TimesBusinessSalesforce CEO points to a record quarter as AI fears about replacing enterprise software fadeThe Apex TimesBusinessNetflix rolls out main poster and trailer for “Delusion,” setting an eye-opening September 24 releaseThe Apex TimesBusinessModerna’s market value is being priced more for its pipeline than its current revenue, analysis saysThe Apex TimesBusinessPalantir’s Pentagon Maven milestone and guidance raise reshape how investors view its government businessThe Apex TimesBusinessNvidia on pace for record growth as Wall Street digests guidance and pace of revenue expansionThe Apex TimesBusinessCVS Health refreshes its board with a data-and-analytics leader and spotlights youth soccer amid questions about its investment narrativeThe Apex TimesBusinessConsumer stocks outside the AI trade have risen sharply this year, trouncing Nvidia in a new market comparisonThe Apex TimesBusinessTarget introduces “Beauty Studio,” pitching a curated cosmetics shop-in-shop with 1,600 products and 90 brandsThe Apex Times
Back to front
On NVIDIA Earnings Day, ARK’s Funds Added About $20M in AVGO Shares, a Rival Chip Bet
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 27, 1:01 AM EDT

On NVIDIA Earnings Day, ARK’s Funds Added About $20M in AVGO Shares, a Rival Chip Bet

Cathie Wood’s ARK Investment Management bought 57,705 shares of AVGO across three funds, according to a market-news report published on NVIDIA’s earnings day.

3 min readEditor-approved Apex article

Cathie Wood’s ARK Investment Management made a visible move in the semiconductor space on NVIDIA’s earnings day, adding shares of AVGO, a widely held rival chip stock. A market-news post citing a transaction summary said ARK purchased a total of 57,705 AVGO shares across three of its funds, with the combined value described as roughly $20 million.

The timing is notable because earnings days often drive rapid shifts in investor sentiment across the chip supply chain, including companies viewed as alternative beneficiaries of demand for data-center infrastructure, networking, and custom silicon. In that context, the ARK activity suggested the firm was not waiting to express a view solely through NVIDIA-related catalysts, but also through a separate, competing equity exposure.

According to the report, the purchases were split among three ARK-managed funds. The post did not name the exact share weights by fund, nor did it specify the execution dates down to the trading window, other than placing the activity in the same day frame as NVIDIA’s reported results.

The transaction description also did not provide several details that typically matter for interpreting how aggressive the trade was. It did not disclose the average buy price, the prior position size in AVGO for each of the three funds, or whether the buys were matched against sales elsewhere in the same period. Without those figures, the motivation behind the trade, such as reducing a risk gap, adding on a technical dip, or initiating a new exposure, remains unclear from the post alone.

Even so, AVGO’s presence in ARK’s portfolio is consistent with how actively managed exchange-traded and mutual fund strategies often operate in the technology sector. Rather than limiting exposure to a single company, these funds commonly rotate among perceived “winners” within a theme, including semiconductor platform providers and infrastructure players.

For NVIDIA, the company’s earnings day routinely becomes a market-wide reference point, not just for its own stock. Semiconductor investors frequently use results from the AI accelerator supplier as a proxy for broader end-demand, including spending by cloud service providers and enterprise customers. A rival-chip purchase on that day can be read as an implicit announcement that ARK was treating NVIDIA’s outlook as only one part of a larger ecosystem rather than the sole driver.

Still, the report did not indicate whether AVGO is being treated as a direct alternative to NVIDIA in customers’ spending plans, or whether it represents a different segment of the hardware stack. The lack of explanation in the market-news post also means it does not clarify whether ARK sees AVGO as benefiting from the same AI build-out, from adjacent networking demand, or from another technology cycle entirely.

What to watch next is whether ARK continues to build the position after the immediate earnings-day window, and whether broader semiconductor peers see follow-on buying or selling from ARK-managed funds. Traders will also likely look for disclosures or reporting that shows the fund-level holdings and average costs, because those figures help distinguish between a small satellite trade and a bigger strategic tilt. For now, the publicly summarized transaction points to a focused, near-term addition to AVGO, but it leaves most of the “why” and “how much” questions unanswered.

Why It Matters

  • Moves by large active managers can influence short-term liquidity and sentiment in high-attention semiconductor stocks, especially around earnings days.
  • Purchasing a rival chip stock on NVIDIA’s earnings day suggests ARK is not treating NVIDIA results as the only catalyst for its semiconductor thesis.
  • Because the report lacks execution and holdings details, the buys are best interpreted as a announcement of active repositioning rather than a fully documented change in long-term strategy.

Sources

Key Facts

  • ARK Investment Management purchased a total of 57,705 shares of AVGO across three ARK funds.
  • The market-news report described the aggregate purchase value as about $20 million.
  • The trades were reported as occurring on NVIDIA’s earnings day.
  • The post did not specify fund names, average execution prices, or position sizes before the buys.

Technology Related